Voice showdown: laser vs. radiation for early throat cancer
NCT ID NCT04057209
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two standard treatments for early-stage larynx cancer: laser surgery and a newer, more precise radiation therapy that targets only the affected vocal cord. The main goal is to see which approach better preserves voice quality over two years. About 34 adults with stage 0 or I glottic cancer will be randomly assigned to one of the treatments and will report their voice function using a questionnaire.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLOTTIS TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Inselspital, Bern University Hospital
RECRUITINGBern, Canton of Bern, 3010, Switzerland
-
Institut Gustave Roussy
RECRUITINGParis, 94805, France
-
Tata Memorial Hospital Mumbai
RECRUITINGMumbai, Maharashtra, 400012, India
-
University Hospital Zurich
RECRUITINGZurich, Canton of Zurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study probes why patients delay throat cancer diagnosis
- New imaging technique reveals how laryngectomy patients produce substitute voice
- Could a Chemo-Immunotherapy cocktail spare head and neck cancer patients from radiation?
- New drug duo offers hope for hard-to-treat head and neck cancer
- New MRI-Guided radiation trial aims to sharpen cancer treatment
- AI messages aim to curb drinking in cancer survivors